• A Case of Contact Toxic Epidermal Necrolysis
• A nationwide study of Stevens-Johnson syndrome and toxic epidermal necrolysis in hospitalized pregnant women in the United States, 2009-2020
• A phase 1/1b, open-label, dose-escalation study of PD-1 inhibitor, cetrelimab alone and in combination with FGFR inhibitor, erdafitinib in Japanese patients with advanced solid tumors
• A Review of the Use of Intravenous Immunoglobulin Therapy in Dermatology
• A systematic review of case-control studies of cytokines in blister fluid and skin tissue of patients with Stevens Johnson syndrome and toxic epidermal necrolysis
• Absence of Epidermal Antibodies in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Patients but Beware of Single Positive Results
• Afatinib-induced toxic epidermal necrolysis: A case report with a literature review
• Allopurinol: Clinical Considerations in the Development and Treatment of Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, and Other Associated Drug Reactions
• Alteration of Gene Expression in Pathological Keratinization of the Ocular Surface
• Amnion as an Innovative Antiseptic Carrier: A Comparison of the Efficacy of Allogeneic and Xenogeneic Transplantations in the Context of Burn Therapy
• Antibiotic-induced severe cutaneous adverse reactions: a single-center retrospective study over ten years
• Antiepileptic Medication-induced Severe Cutaneous Adverse Reactions in Hospitalized Children: A Retrospective Study
• Atezolizumab combined with immunogenic salvage chemoimmunotherapy in patients with transformed diffuse large B-cell lymphoma
• Atypical Presentation of Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) in a Patient on Pembrolizumab: A Case Report
• Bevacizumab-associated toxic epidermal necrolysis in a patient with liver cancer
• Candidemia and Candida colonization in patients with epidermal necrolysis: a retrospective case series
• Causality Assessment of Adverse Drug Reaction Toxic Epidermal Necrolysis With the Aid of ChatGPT: A Case Report
• Characterizing drug-induced epidermal necrolysis in a pediatric cohort
• Characterizing immune checkpoint inhibitor-related cutaneous adverse reactions: A comprehensive analysis of FDA adverse event reporting system (FAERS) database
• Chinese expert consensus on diagnosis and treatment of immune checkpoint inhibitor-related skin adverse reactions (2024 edition)
• Chronic Stevens-Johnson Syndrome Heralding a Fascinating Etiology
• Clues of HLAs, metabolic SNPs, and epigenetic factors in T cell-mediated drug hypersensitivity reactions
• Co-occurrence of oral pemphigus vulgaris and herpes simplex virus infection in a young patient with Crohn's disease: report of a rare case of oral lesions during anti-TFN alpha and immunomodulator therapy
• Comparison of incidence, causes and prognosis of adult and pediatric epidermal necrolysis: a population-based study in France
• Delayed Inflammatory Reaction to Hyaluronic Acid Dermal Filler Following Zoledronic Acid Administration: A Case Report
• Delayed skin testing for systemic medications: helpful or not?
• Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome Preceding Toxic Epidermal Necrolysis Secondary to Sildenafil: A Case Report
• Eczema herpeticum in an immunocompetent man
• Empowering advanced clinical practitioners in managing acute dermatological emergencies
• Enfortumab Vedotin Drug Eruption: Cutaneous Adverse Events and Histopathologic Findings
• Erythema Multiforme and Epidermal Necrolysis Following COVID-19 Vaccines: A Systematic Review
• Erythema multiforme associated with the immune checkpoint inhibitors: A disproportionality analysis using the FDA Adverse Event Reporting System
• Evaluation of adjuvant role of topical cyclosporine 1% in acute Stevens-Johnson syndrome: a randomised control trial
• Evaluation of the Factors Influencing Mortality in Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Multicenter Study of 166 Patients
• Flagellate-like presentation of Stevens-Johnson syndrome: Toxic epidermal necrolysis after gefitinib therapy
• French national protocol for diagnosis and management of epidermal necrolysis in adults (Stevens-Johnson syndrome and toxic epidermal necrolysis)
• Furmonertinib-Induced Toxic Epidermal Necrolysis in a Patient with Advanced Lung Adenocarcinoma
• Generalized Fixed Drug Eruptions Require Urgent Care: A Case Series
• Greater mechanistic understanding of the cutaneous pathogenesis of Stevens-Johnson syndrome/toxic epidermal necrolysis can shed light on novel therapeutic strategies: a comprehensive review
• Ibuprofen-Induced Pancytopenia and Erythema Multiforme in an Elderly Female Patient
• Immune checkpoint inhibitor associated epidermal necrosis, beyond SJS and TEN: a review of 98 cases
• Immunological Drug-Drug Interactions Affect the Efficacy and Safety of Immune Checkpoint Inhibitor Therapies
• Improvement of the Ocular Prognosis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A National Survey in Japan
• JAAD Game Changers: "Etanercept therapy for toxic epidermal necrolysis"
• Lamotrigine Emerging as a Driver of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An 8-Year Retrospective Study
• Lid Margin Microbiome in Stevens-Johnson Syndrome Patients With Lid Margin Keratinization and Severe Dry Eye Disease
• Lid-wiper keratopathy and mucous membrane grafting
• Life-threatening Rash Due to Lamotrigine and a Failure to Understand Its Pharmacology: How Forensic Detective Work Uses Medical Knowledge and Clinical Pharmacology to Solve Cases
• Line-field Confocal Optical Coherence Tomography (LC-OCT) for real-time differential diagnosis of toxic epidermal necrolysis versus staphylococcal scalded skin syndrome leading to an optimal initial management
• Management of pain in the inpatient and non-surgical outpatient dermatology settings: A narrative review
• Methotrexate might become the sole treatment option for leukemia following the occurrence of Stevens-Johnson syndrome
• Moderate and serious adverse reactions to antimicrobials among hospitalized children: A systematic review
• Ocular aspects of toxic epidermal necrolysis
• Ocular involvement in Steven-Johnson syndrome/toxic epidermal necrolysis: recent insights into pathophysiology, biomarkers, and therapeutic strategies
• Outcome measurements in epidermal necrolysis: a systematic review
• Paraneoplastic dermatomyositis and Stevens-Johnson syndrome related to immunotherapy
• Pediatric Stevens-Johnson syndrome/toxic epidermal necrolysis overlap; time to draw up treatment guidelines?
• Pembrolizumab-induced Stevens-Johnson syndrome/Toxic Epidermal Necrolysis in a Vietnamese patient with nonsmall-cell lung cancer
• Prevalence of limbal stem cell deficiency at an academic referral center over a two-year period
• Prognostic significance of the Systemic Immune-Inflammation Index in Steven-Johnson Syndrome and Toxic Epidermal Necrolysis (SJS/TEN) patients
• Promising response to Wharton's jelly eye drops in severe ocular involvement during acute phase of epidermal necrolysis and erythema multiforme major
• Protein Haptenation and Its Role in Allergy
• Pyrazinamide-induced Toxic Epidermal Necrolysis
• Recent progress of Stevens-Johnson syndrome/toxic epidermal necrolysis: Diagnosis criteria, pathogenesis and therapy
• Relevance of Drug Hypersensitivity Evaluations in the Setting of a Polymedicated Patient with Stevens-Johnson Syndrome: Colchicine Unmasked
• Retrospective Cohort Study Characterizing PD-1/PD-L1 Checkpoint Inhibition Associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
• Risk factors for the development of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis, following drug administration: a systematic review and meta-analysis
• Role of neutrophil-lymphocyte ratio as a prognostic marker in SJS/TEN patients
• Safety evaluation of ceftazidime/avibactam based on FAERS database
• Skin-Related Adverse Reactions Induced by Oral Antidiabetic Drugs-A Review of Literature and Case Reports
• Stevens-Johnson syndrome and toxic epidermal necrolysis associated with immune checkpoint inhibitors: a systematic review
• Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Analysis of the Russian Database of Spontaneous Reports
• Stevens-Johnson syndrome associated with pancytopenia: a case report
• Stevens-Johnson syndrome-toxic epidermal necrolysis overlap in a patient taking quetiapine and famotidine: a case report
• Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis: Macules, Papules, and Bullae
• Stevens-Johnson syndrome/toxic epidermal necrolysis associated with natural thyroid medication
• Strategic testing following toxic epidermal necrolysis allows reintroduction of chemotherapy in a patient with progressive myeloma
• The Clinical Outcomes of Minor Salivary Gland Transplantation for Severe Dry Eye Disease Secondary to Chronic Stevens-Johnson Syndrome
• The Occurrence of Etoricoxib-Induced Stevens-Johnson Syndrome With Oral Manifestations in a Female Patient: A Case Study
• The overlap Stevens-Johnson syndrome due to meropenem administration. Clinical case and nursing care
• The quality-of-life impact of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) on patients' lives: An interpretative descriptive qualitative study
• The Role of NLRP3 Inflammasome in the Pathogenesis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
• The spectrum of cutaneous toxicities related to novel genitourinary cancer therapies
• The Use of Biologic Agents for the Treatment of Cutaneous Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Review of Reported Cases
• Tislelizumab-Induced Toxic Epidermal Necrolysis-Like Cutaneous Adverse Reaction: Rare Complication of Immune Checkpoint Inhibitor Therapy
• Topical imiquimod adverse event: Beyond the local skin reaction-A case report
• Toxic Epidermal Necrolysis After COVID-19 Vaccination: A Case Report and Review of Literature
• Toxic Epidermal Necrolysis Caused by Eribulin
• Toxic epidermal necrolysis caused by phenobarbital: a case report and literature review
• Toxic epidermal necrolysis caused by viral hepatitis A: a case report and literature review
• Toxic epidermal necrolysis-like cutaneous toxicity following chimeric antigen receptor T-cell therapy in recurrent large B-cell lymphoma
• Toxic epidermal necrolysis-like linear IgA bullous dermatosis as a manifestation of multiple drug hypersensitivity in the setting of drug reaction with eosinophilia and systemic symptoms
• Toxic Flexural Epidermolysis in hospitalized patients
• Trastuzumab-induced toxic epidermal necrolysis in a Her-2-positive metastatic breast cancer patient-A rare case report
• Treatment of Tislelizumab-Induced Toxic Epidermal Necrolysis and Agranulocytosis: A Case Report and Literature Review
• Trichiasis in cicatricial ocular surface disease: a multi-center comparison of electroepilation versus eyelash resection outcomes
• Tumor necrosis factor inhibitors enhance corticosteroid therapy for Stevens-Johnson syndrome and toxic epidermal necrolysis linked to immune checkpoint inhibitors: a prospective study
• Uncommon toxic epidermal necrolysis -like presentation of cutaneous lupus erythematosus: A series of 6 cases
• Urticaria multiforme in Asian children
• Utility of the Severity-of-Illness Score for Toxic Epidermal Necrolysis (SCORTEN) in Pediatric Stevens-Johnson Syndrome Patients